Replies to post #158890 on Elite Pharmaceuticals Inc (ELTP)

[no2koolaid]

Perhaps Purdue Pharma is relying on the Pareto Principle to support Hysingla. Still, if my memory of quantitative analysis is reliable, a p<.0001 is REALLY SIGNIFICANT. Thanks for the comparison. Although I suspect it is not one that Purdue would be proud of. So we should not expect that one of Purdue's marketing slogans will be..."WE CANNOT COMPETE WITH ELITE!"

This does raise a point I have made, perhaps ad nauseam...Elite does not have to be the market leader nor the maker of the best ADFs around. All they need to do is have something that can compete in the opioid pain med market when the FDA and other regulators decide that the only way to compete in that market is with ADFs.